Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
松弛的聚合酶暂停是表观遗传可塑性和癌细胞侵袭的驱动因素
基本信息
- 批准号:10747536
- 负责人:
- 金额:$ 6.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcetylationBehaviorBreastBreast Cancer CellBreast Epithelial CellsCellsChromatinComplexDNA PackagingDNA Polymerase IIDNA-Directed RNA PolymeraseDevelopmentDiagnosisDiseaseDistant MetastasisDown-RegulationEnvironmentEpigenetic ProcessEpitheliumExhibitsGenesGenetic TranscriptionHeterogeneityHistone H4HybridsInvadedMalignant NeoplasmsMediatingMesenchymalMetastatic breast cancerModelingModificationMolecularPatientsPhenotypePlayPolymeraseProcessPropertyReaderRegulationRelaxationRepressionResidual stateRoleRunningSiteSmall Nuclear RibonucleoproteinsSourceTechnologyTherapeutic InterventionTransforming Growth Factor betacancer cellcancer survivalchemical stabilityepithelial to mesenchymal transitionflexibilityhistone methyltransferaseinsightmalignant breast neoplasmmortalityneoplastic cellnovelpackaging materialprogramsrecruitstem
项目摘要
Project Summary
The development of distant metastases accounts for a significant proportion of breast cancer mortality; as many
as 30% of patients initially diagnosed at an early stage will eventually progress to metastatic disease. A key early
step in metastatic progression is an increase in cellular plasticity that enables a subset of tumor cells to lose
residual epithelial features and gain migratory and invasive behavior, molecularly reflected in the epithelial to
mesenchymal transition (EMT). Considerable evidence now points to cancer-associated EMT as a highly
dynamic and reversible process with disseminated cancer cells exhibiting many hybrid intermediate states
(partial-EMT) proposed to possess the greatest potential for aggressive, stem-like, behavior. However, the
epigenetic mechanisms that control such phenotypic plasticity and the role of this process in early invasion
remain incompletely understood. Recently we discovered that the local regulation of RNA polymerase (Pol II)
pause release by the histone methyltransferase SUV420H2 plays an important role in stabilizing the epithelial
‘identity’ of luminal breast cancer cells and in so doing, suppresses breast cancer cell invasion. Specifically, we
find that the local conversion of H4K20me1 to me3 by SUV420H2 enforces RNA polymerase pausing by blocking
recruitment of the MOF/MSL complex, which is in turn necessary for the acetylation of H4K16, recruitment of
pTEFb and Pol II pause release. We further find that SUV420H2-mediated repression constrains the
mesenchymal program in luminal breast epithelial cells, yet is directed to new sites upon TGF-β induced EMT.
SUV420H2 is downregulated in triple negative/basal subtype of breast cancers, and its forced downregulation
or inhibition promotes collective invasion in breast cell spheroids grown in 3D. These and other findings lead us
to propose that the relaxation of SUV420H2-mediated Pol II pausing control is one source of the epigenetic
plasticity and transcriptional heterogeneity that underlies breast cancer cell adaptation and the emergence of
tumor cells with invasive properties. Using a combination of precision run-on sequencing (Pro-seq) and native
chromatin analyses via CUT&Tag technology, we will determine the how the SUV420H2 mediated pause
constraints enforces phenotypic stability and how loss of these constraints allows for transcriptional promiscuity.
We will explore the role of the HEXIM1 / 7SK snRNP complex as a novel ‘reader’ of histone H4 modifications
and its role in SUV420H2-mediated pause control. Lastly, we will determine the impact of dysregulated Pol II
pausing dynamics on transcriptional diversity and the emergence of breast cells with invasive “leader” potential
in a 3D spheroid model of collective invasion. Over the long term, the results of our studies will provide important
insight into the mechanisms underlying epigenetic plasticity and its role in tumor cell adaptation, and a framework
for the development of novel reprogramming strategies to block breast cancer metastatic progression.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paula M. Vertino其他文献
TGF-β1-mediated intercellular signaling fuels cooperative cellular invasion
转化生长因子-β1(TGF-β1)介导的细胞间信号传导促进了细胞的协同侵袭。
- DOI:
10.1016/j.celrep.2025.115315 - 发表时间:
2025-02-25 - 期刊:
- 影响因子:6.900
- 作者:
Tala O. Khatib;Brian A. Pedro;Sergei Bombin;Veronika Y. Matsuk;Isaac E. Robinson;Sarah F. Webster;Landon J. Marcus;Emily R. Summerbell;Gregory K. Tharp;Christina M. Knippler;Pritha Bagchi;Jeanne Kowalski-Muegge;H. Rich Johnston;Homa Ghalei;Paula M. Vertino;Janna K. Mouw;Adam I. Marcus - 通讯作者:
Adam I. Marcus
Methylation matters: a new spin on maspin
甲基化很重要:maspin 的新视角
- DOI:
10.1038/ng0602-123 - 发表时间:
2002-06-01 - 期刊:
- 影响因子:29.000
- 作者:
Joseph F. Costello;Paula M. Vertino - 通讯作者:
Paula M. Vertino
emArid1a/em mutation suppresses TGF-β signaling and induces cholangiocarcinoma
emArid1a/em 突变抑制 TGF-β信号传导并诱导胆管癌
- DOI:
10.1016/j.celrep.2022.111253 - 发表时间:
2022-08-30 - 期刊:
- 影响因子:6.900
- 作者:
Bing Guo;Scott C. Friedland;William Alexander;Jacquelyn A. Myers;Wenjia Wang;Michael R. O’Dell;Michael Getman;Christa L. Whitney-Miller;Diana Agostini-Vulaj;Aaron R. Huber;Stephano S. Mello;Paula M. Vertino;Hartmut K. Land;Laurie A. Steiner;Aram F. Hezel - 通讯作者:
Aram F. Hezel
Paula M. Vertino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paula M. Vertino', 18)}}的其他基金
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
松弛的聚合酶暂停是表观遗传可塑性和癌细胞侵袭的驱动因素
- 批准号:
10600087 - 财政年份:2021
- 资助金额:
$ 6.26万 - 项目类别:
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
松弛的聚合酶暂停是表观遗传可塑性和癌细胞侵袭的驱动因素
- 批准号:
10378710 - 财政年份:2021
- 资助金额:
$ 6.26万 - 项目类别:
2010 FASEB Conference "Biological Methylation:From DNA to Histones and Beyond"
2010年FASEB会议“生物甲基化:从DNA到组蛋白及其他”
- 批准号:
7911239 - 财政年份:2010
- 资助金额:
$ 6.26万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
8246510 - 财政年份:2009
- 资助金额:
$ 6.26万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
8069622 - 财政年份:2009
- 资助金额:
$ 6.26万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
7742918 - 财政年份:2009
- 资助金额:
$ 6.26万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
7843531 - 财政年份:2009
- 资助金额:
$ 6.26万 - 项目类别:
Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
定义人类癌症中异常 DNA 甲基化的基因组特征
- 批准号:
8459567 - 财政年份:2009
- 资助金额:
$ 6.26万 - 项目类别:
GENESIS AND CONSEQUENCES OF ABERRANT DNA METHYLATION
异常 DNA 甲基化的起源和后果
- 批准号:
6164264 - 财政年份:1998
- 资助金额:
$ 6.26万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 6.26万 - 项目类别: